Ontology highlight
ABSTRACT: Background
With the disappointing outcomes of clinical trials on patients with Alzheimer's disease or mild cognitive impairment (MCI), there is increasing attention to understanding cognitive decline in normal elderly individuals, with the goal of identifying subjects who are most susceptible to imminent cognitive impairment.Purpose/hypothesis
To evaluate the potential of cerebral blood flow (CBF) as a biomarker by investigating the relationship between CBF at baseline and cognition at follow-up.Study type
Prospective longitudinal study with a 4-year time interval.Population
309 healthy subjects aged 20-89 years old.Field strength/sequence
3T pseudo-continuous-arterial-spin-labeling MRI.Assessment
CBF at baseline and cognitive assessment at b
SUBMITTER: De Vis JB
PROVIDER: S-EPMC6028323 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature